Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: Randomised placebo-controlled trial

Lancet

Volumn 366, Issue 9497, 2005, Pages 1622-1632

  Chen, Zhengming ^a   Xie, Jinxiang ^b  

^a CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^b FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METOPROLOL; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ASTHMA; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRAIN HEMORRHAGE; BRONCHOSPASM; CARDIOGENIC SHOCK; CARDIOPULMONARY HEMODYNAMICS; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; HAZARD ASSESSMENT; HEART ARREST; HEART BUNDLE BRANCH BLOCK; HEART DEATH; HEART FAILURE; HEART RUPTURE; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SAMPLE SIZE; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 27644531361     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67661-1     Document Type: Article

References (35)

1. S Yusuf, R Peto, J Lewis, R Collins, P Sleight Beta-blockade during and after myocardial infarction: an overview of the randomised trials Prog Cardiovasc Dis 27 1985 335 371
2. A Statement for healthcare professionals from the American Heart Association and the American College of Cardiology. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update Circulation 104 2001 1577 1579
3. Third Joint Task Force of the European and other Societies on Cardiovascular Disease Prevention in Clinical Practice European guidelines on cardiovascular disease prevention in clinical practice Eur Heart J 24 2003 1601 1610
4. The Task Force on Beta-blockers of the European Society of Cardiology Expert consensus document on β-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
5. CIBIS-II investigators and committees The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
6. MERIT-HF study group Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
7. The MIAMI Trial Research Group metoprolol in acute myocardial infarction (MIAMI). A randomised placebo controlled international trial Eur Heart J 6 1985 199 211
8. J Herlitz, F Waagstein, J Lindqvist, K Swedberg, A Hjalmarson Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial) Am J Cardiol 80 1997 40J 44J
9. ISIS-1 collaborative group Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS 1 Lancet 2 1986 57 66
10. A Owen Intravenous beta-blockade in acute myocardial infarction: should be used in combination with thrombolysis BMJ 317 1998 226 227
11. M Pfisterer, JL Cox, CB Granger Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience J Am Coll Cardiol 32 1998 634 640
12. JH Gurwitz, RJ Goldberg, Z Chen, JM Gore, JS Alpert Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly Am J Med 93 1992 605 610
13. KL Woods, D Ketley, A Lowy β-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction: towards an understanding of factors influencing clinical practice Eur Heart J 19 1998 74 79
14. WJ Rogers, JG Canto, CT Lambrew Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 to 1999: the National Registry of Myocardial Infarction 1, 2 and 3 J Am Coll Cardiol 36 2000 2056 2063
15. ISIS-1 collaborative group Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction Lancet 1 1988 921 923
16. Fibrinolytic Therapy Trialists' (FTT) collaborative group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 1994 311 322
17. R Roberts, WJ Rogers, HS Mueller Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II-B study Circulation 83 1991 422 437
18. F Van de Werf, L Janssens, T Brzostek Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardiac infarction receiving thrombolytic therapy J Am Coll Cardiol 22 1993 407 416
19. S Basu, R Senior, U Raval, R van der Does, T Bruckner, A Lahiri Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction: a placebo-controlled, randomised trial Circulation 96 1997 183 191
20. CCS-2 collaborative group Rationale, design and organisation of the Second Chinese Cardiac Study (CCS-2): a randomised trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction J Cardiovasc Risk 7 2000 435 441
21. COMMIT collaborative group Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1607 1621
22. Chinese Cardiac Study collaborative group Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) Lancet 345 1995 686 687
23. R Peto, MC Pike, P Armitage Design and analysis of randomized clinical trials requiring prolonged observation of each patient Br J Cancer 34 1976 585 612
24. DR Cox Regression models and life-tables J R Stat Soc 34 1972 187 220
25. N Freemantle, J Cleland, P Young, J Mason, J Harrison β-blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737
26. MJ Kendall, KP Lynch, A Hjalmarson, J Kjekshus Beta-blockers and sudden cardiac death Ann Intern Med 123 1995 358 367
27. HL Kennedy Beta blockade, ventricular arrhythmias, and sudden cardiac death Am J Cardiol 80 1997 29J 34J
28. SG Priori, E Aliot, C Blomström-Lundqvist Task force on sudden cardiac death of the European Society of Cardiology Eur Heart J 22 2001 1374 1450
29. SD Solomon, S Zelenkofske, JJ McMurray Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both N Engl J Med 352 2005 2581 2588
30. RJ Goldberg, JM Gore, JS Alpert Cardiogenic shock after acute myocardial infarction. incidence and mortality from a community-wide perspective, 1975 to 1988 N Engl J Med 325 1991 1117 1122
31. RM Califf, JR Bengston Cardiogenic shock N Engl J Med 330 1994 1724 1730
32. RJ Goldberg, NA Samad, J Yarzebski, J Gurwitz, C Bigelow, JM Gore Temporal trends in cardiogenic shock complicating acute myocardial infarction N Engl J Med 340 1999 1162 1168
33. H Elatchaninoff, C Simpfendorfer, I Franco, RE Raymond, PN Casale, PL Whitlow Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: a retrospective study comparing coronary angioplasty with medical treatment Am Heart J 130 1995 459 464
34. HH Zhou, RP Koshakji, DJ Silberstein, GR Wilkinson, AJ Wood Racial differences in drug response: altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American Whites N Engl J Med 320 1989 565 570
35. V Menon, JN Slater, HD White, LA Sleeper, T Cocke, JS Hochman Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry Am J Med 108 2000 374 380